In silico machine learning methods in drug development

Current Topics in Medicinal Chemistry

Volumn 14, Issue 16, 2014, Pages 1913-1922

  Dobchev, Dimitar A ^a   Pillai, Girinath G ^b,c   Karelson, Mati ^a,b  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c University of Florida   (United States)

Author keywords

Artificial neural network; Genetic programming; Machine learning; QSAR; Support vector machine

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; ARTIFICIAL NEURAL NETWORK; AUTOIMMUNE DISEASE; BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; CLASSIFICATION ALGORITHM; COMPUTER MODEL; DATA MINING; DEGENERATIVE DISEASE; DRUG ACTIVITY; DRUG DESIGN; DRUG DEVELOPMENT; DRUG SCREENING; GASTROINTESTINAL DISEASE; GENETIC ALGORITHM; HUMAN; LEARNING ALGORITHM; MACHINE LEARNING; MULTIPLE LINEAR REGRESSION ANALYSIS; NEOPLASM; NONHUMAN; PARTIAL LEAST SQUARES REGRESSION; PERCEPTRON; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SUPPORT VECTOR MACHINE; VIRUS INFECTION; ALGORITHM; ARTIFICIAL INTELLIGENCE;

ALGORITHMS; ARTIFICIAL INTELLIGENCE; DRUG DESIGN; HUMANS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84911446995     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026614666140929124203     Document Type: Article

References (79)

1. Engelbrecht, A.P. Computational intelligence: An introduction. J. Wiley: New York, 2003.
2. nd Ed.; J.Wiley: New York, 2001.
3. Konar, A. Computational intelligence; principles, techniques and applications. Springer: Berlin, 2005.
4. Webb, A. Statistical pattern recognition. J. Wiley: New York, 2002.
5. Hastie, T.; Tibshirani, R.; Friedman, J. The elements of statistical learning. Springer: Berline, 2001.
6. Jang, J.S.; Sun, C.T.; Mizutani, E. Neuro-Fuzzy and Soft Computing; A Computational Approach to Learning and Machine Intelligence, Robbins, T., Ed.; Pentice Hall, Inc.: New Jersey, 1997.
7. Katritzky, A.; Kuanar, M.; Slavov, S.; Hall, C.; Karelson, M.; Kahn, I.; Dobchev, D. (2010). Quantitative Correlations of Physical and Chemical Properties with Chemical Structure; Utility for Prediction. Chem. Rev., 2010, 110(10), 5714 - 5789.
8. Katritzky, A.R.; Dobchev, D.A.; Karelson, M. Physical, chemical, and technological property correlation with chemical structure: The potential of QSPR. Zeitschrift für Naturforschung B. J. Chem. Sci., 2006, 61(4), 373 - 384.
9. De Benedetti, P.G.; Fanelli, F. Computational quantum chemistry and adaptive ligand modeling in mechanistic QSAR. Drug Discov. Today, 2010, 15(19-20), 859-866.
10. Mazzatorta, P.; Benfenati, E.; Lorenzini, P.; Vighi, M. QSAR in Ecotoxicity: An Overview of Modern Classification Techniques, J. Chem. Inf. Comput. Sci., 2004, 44, 105-112.
11. Sharma, O.P.; Saini, N.K.; Gupta, V.; Sachdeva, K.; Arya, H. Evolutionary History of QSAR: A Review. J. Natur. Cons., 2011, 1(4), 266-272.
12. Oprea, T.I. On the information content of 2D and 3D descriptors for QSAR. J. Braz. Chem. Soc., 2002, 13(6), 811-815.
13. Guha, R.; Stanton, D.T.; Jurs, P.C. Interpreting Computational Neural Network Quantitative Structure-Property Relationship Models: A Detailed Interpretation of the Weights and Biases. J. Chem. Inf. Mod. 2005, 45, 1109.
14. Berhanu, W.M.; Pillai, G.G.; Oliferenko, A.A.; Katritzky, A.R. Quantitative Structure-Activity/Property Relationships: The Ubiquitous Links between Cause and Effect. Chem.Plus.Chem, 2012, 77(7), 507-517.
15. Karelson M. Molecular Descriptors in QSAR/QSPR. Wiley- Interscience: New York, 2000.
16. Katritzky, A.R.; Mu, L.; Lobanov, V. S.; Karelson, M. Correlation of Boiling Points With Molecular Structure. 1. A Training Set of 298 Diverse Organics and a Test Set of 9 Simple Inorganics. J. Phys. Chem. 1996, 100, 10400-10407.
17. Karelson, M.; Dobchev, D.A.; Karelson, G.; Tamm, T.; Tämm, K.; Nikonov, A.; Mutso, M.; Merits, A. Fragment-based development of HCV protease inhibitors for the treatment of hepatitis C. Curr. Comput-Aid. Drug Des., 2012, 8(1), 55 - 61.
18. Katritzky, A.R.; Slavov, S.H.; Dobchev, D.A.; Karelson, M. QSAR modeling of the antifungal activity against Candida albicans for a diverse set of organic compounds. Bioorgan. Med. Chem., 2008, 16(14), 7055 - 7069.
19. Goudarzi, N.; Goodarzi, M.; Chen, T. QSAR prediction of HIV inhibition activity of styrylquinoline derivatives by genetic algorithm coupled with multiple linear regressions. Med. Chem. Res., 2012, 21(4), 437-443.
20. Katritzky, A.R.; Slavov, S.; Dobchev, D.A.; Karelson, M. Comparison Between 2D and 3D-QSAR Approaches to Correlate Inhibitor Activity for a Series of Indole Amide Hydroxamic Acid. QSAR Comb. Sc., 2007, 26(3), 333 - 345.
21. Weber, K.C.; Honório, K.M.; Bruni, A.T.; Andricopulo, A.D.; da Silva, A.B.F. A partial least squares regression study with antioxidant flavonoid compounds. Struct. Chem., 2006, 17(3), 307-313.
22. Stanton D,T QSAR and QSPR model interpretation using partial least squares (PLS) analysis. Curr Comput-Aid. Drug Des., 2012, 8(2), 107-27.
23. Olah, M.; Bologa, C.; Oprea, Y.I. An automated PLS search for biologically relevant QSAR descriptors, J. Comput Aid. Mol. Des., 2004, 18, 437-449.
24. Witten, I.H.; Frank, E. Data Mining: Practical Machine Learning Tools and Techniques. Morgan Kaufmann Inc.: Massachusetts, 2005.
25. Kitchen, D.B.; Stahura, F.L.; Bajorath, J. Computational techniques for diversity analysis and compound classification. Mini Rev. Med. Chem., 2004, 4(10), 1029-39.
26. nd Ed., MIT Press: Cambridge, 2002
27. Haykin, S. Neural Networks A comprehensive foundation; Pearson: London, 1999.
28. Zupan, J.; Gasteiger, J. Neural networks in chemistry and drug design. Wiley-VCH: Weinheim, 1999.
29. rd Ed., Springer: Berlin, 2000.
30. Konar, A. Computational intelligence; principles, techniques and applications. Springer:Berlin, 2005.
31. Lu, W.J.; Chen, Y.L.; Ma, W.P.; Zhang, X.Y.; Luan, F.; Liu, M.C.; Chen, X.G.; Hu, Z.D. QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network. Eur. J. Med. Chem., 2008, 43, 569-576.
32. Gharagheizi, F. QSPR analysis for intrinsic viscosity of polymer solutions by means of GA-MLR and RBFNN. Comput. Mater. Sci., 2007, 40, 159-167.
33. Winkler, D.A.; Burden, F.R. Application of Neural Networks to Large Dataset QSAR, Virtual Screening, and Library Design. In: Combinatorial Library, Methods in Molecular Biology. English, L. B. Ed., Springer Protocols: New Jersey, 2002, pp. 325-367.
34. Bishop, C.M. Neural Networks for Pattern Recognition. Oxford University Press: Oxford, 2005.
35. Neal, R.M. Bayesian Learning for Neural Networks, Lecture Notes in Statistics, Springer: New York, 1996.
36. Vapnik, V. Principles of Risk Minimization for Learning Theory. In Advances in Neural Information Processing Systems, Moody, J. E.; Hanson, S.J.; Lippmann, R.P. Eds.; Morgan Kaufmann Publishers, Inc.: Massachusetts, 1992, Vol. 4.
37. Burton, J.; Ijjaali, I.; Petitet, F.; Michel, A.; Vercauteren, D.P. Virtual screening for cytochromes P450: successes of machine learning filters. Comb. Chem. HTS., 2009, 12, 369-382.
38. Sato, T.; Matsuo, Y.; Honma, T.; Yokoyama, S. In silico functional profiling of small molecules and its applications. J. Med. Chem., 2008, 25, 7705-7716.
39. Burges, C.J.C. A tutorial on support vector machines for pattern recognition. Data Min. Knowl. Disc., 1998, 2(2), 121-167.
40. Cristianini, N.; Shawe-Taylor, J. An Introduction to Support Vector Machines, Cambridge University Press: Cambridge, UK, 2000.
41. Scholkopf, B.; Smola, A.J. Learning with Kernels, MIT Press: Cambridge, 2002.
42. Warmuth et al., Active Learning with Support Vector Machines in the Drug Discovery Process. J. Chem.Inf. Comput. Sci., 2003, 43(2): 667-673
43. Doucet, J.P.; Barbault, F.; Xia, H.; Panaye, A.; Fan, B. Non-linear SVM approaches to QSPR/QSAR studies and drug design. Curr. Comput. Aid. Drug Des., 2007, 3, 263-289.
44. Li, H.; Liang, Y.; Xu, Q. Support vector machines and its applications in chemistry. Chemom. Intell. Lab. Syst., 2009, 95,188-198.
45. Holland, J. Adaptation in Artificial and Natural Systems, University of Michigan Press: Ann Arbor, MI, 1975.
46. Friedman, J. Multivariate Adaptive Regression Splines, Technical Report No. 102, Laboratory for Computational Statistics, Department of Statistics, Stanford University; Stanford, CA, Nov, 1988 (revised Aug 1990).
47. Langdon, W.B. and Barrett, S.J. Genetic programming in data mining for drug discovery. In: Ghosh, A.; Jain, L.C., Ed.; Evolutionary Computing in Data Mining. Springer: Berlin, 2004, pp. 211-235.
48. Venkatraman, V.; Dalby, A.R.; Yang, Z.R. Evaluation of mutual information and genetic programming for feature selection in QSAR, J. Chem. Inf. Comp. Sci., 2004, 44, 1686-1692.
49. Yu, J.; Yu, J.; Almal, A.A.; Dhanasekaran, S.M.; Ghosh, D.; Worzel, W.P.; Chinnaiyan, A.M. Feature selection and molecular classification of cancer using genetic programming. Neoplasia, 2007, 9(4), 292-303.
50. Archetti, F.; Giordani, I.; Vanneschi, L.; Genetic programming for QSAR investigation of docking energy, Appl. Soft Comput., 2010, 10, 170-182.
51. Archetti, F.; Messina, E.; Lanzeni, S.; Vanneschi, L. Genetic programming for computational pharmacokinetics in drug discovery and development, Genet. Program. Evol. M., 2007, 8(4), 17-26.
52. Lowen, R.; Verrschoren, A. Eds. Foundation of generic optimization, Springer: Berlin, 2008, Vol. 2.
53. Jain, L.C.; Martin, N.M. Fusion of Neural Networks, Fuzzy Systems and Genetic Algorithms: Industrial Applications, CRC Press: Florida, 2007.
54. Goldberg, D.E. Genetic Algorithms in Search, Optimization and Machine Learning, Addison-Wesley: Boston, 1989.
55. Melanie, M. An Introduction to Genetic Algorithms, MIT Press: Cambridge, 1998.
56. Fraller, D.B. State of the science: use of biomarkers and imaging in diagnosis and management of Alzheimer disease. J. Neurosci. Nurs., 2013, 45, 63-70.
57. Jack, C.R.; Jr, Knopman D. S.; Jagust, W.J.; Shaw, L.M.; Aisen, P.S.; Weiner, M.W.; Petersen, R.C.; Trojanowski, J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol., 2010, 9, 119-128.
58. Hsu, W.C.; Denq, C.; Chen, Su-S. A diagnostic methodology for Alzheimer's disease, J. Clin. Bioinfo., 2013, 3, 9.
59. Si, H.Z.; Wang, T.; Zhang, K.J.; Hua, Z.D.; Fan, B.T. QSAR study of 1,4-dihydropyridine calcium channel antagonists based on gene expression programming, Bioorgan. Med. Chem., 2004, 14, 4834-4841.
60. Li , G-B.; Yang, L-L.; Feng, S.; Jian-Ping Zhou , Qi Huang , Huan- Zhang Xie.Lin-Li Li , Sheng-Yong Yang, Discovery of novel mGluR1 antagonists: A multistep virtual screening approach based on an SVM model and a pharmacophore hypothesis significantly increases the hit rate and enrichment factor. Bioorgan. Med. Chem. Let., 2011, 21, 1736-1740.
61. Li, L. W.; Li, J.; Khanna, M.; Jo, I.; Baird, J. P.; Meroueh, S. O. Docking to Erlotinib Off-Targets Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable in Vitro Pharmacokinetics, ACS Med. Chem. Lett., 2010, 1, 229.
62. Li L.; Khanna, M.; Jo, I.; Wang, F.; Ashpole, N.M.; Hudmon, A.; Meroueh, S.O. Target-Specific Support Vector Machine Scoring in Structure-Based Virtual Screening: Computational Validation, In Vitro Testing in Kinases, and Effects on Lung Cancer Cell Proliferation, J. Chem. Inf. Model, 2011, 51, 755-759.
63. Fan, Y.; Shi, L.M.; Kohn, K.W.; Pommier, Y.; Weinstein, J.N.; Quantitative Structure-Antitumor Activity Relationships of Camptothecin Analogues: Cluster Analysis and Genetic Algorithm-Based Studies, J. Med. Chem., 2001, 44, 3254-3263.
64. Fan, Y.; Weinstein, J.N.; Kohn, K.W.; Shi, L.M.; Pommier, Y. Molecular modeling studies of the DNA - topoisomerase I ternary cleavable complexe with camptothecin. J. Med. Chem.,1998, 41, 2216-2226.
65. Xue, C.X.; Zhang, X.Y.; Liu, M.C.; Hu, Z.D.; Fan, B.T. Study of probabilistic neural networks to classify the active compounds in medicinal plants. J. Pharm. Biomed. An., 2005, 38, 497-507.
66. Yuan, Y.; Zhang, R.; Hu, R.; Ruan. Prediction of CCR5 receptor binding affinity of substituted 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas based on the heuristic method, support vector machine and projection pursuit regression, Eur. J. Med. Chem., 2009, 44, 25-34.
67. Shi, W.; Zhang, X.; Shen, Q. Quantitative structure-activity relationships studies of CCR5 inhibitors and toxicity of aromatic compounds using gene expression programming. Eur. J. Med. Chem., 2010, 45, 49-54.
68. Darnag, R.; Mazouz, E.L.M.; Schmitzer, A.; Villemin, D.; Jarid, A.; Cherqaoui, D. Support vector machines: Development of QSAR models for predicting anti-HIV-1activity of TIBO derivatives. Eur. J. Med. Chem., 2010, 45, 1590-1597.
69. Polanski, J.; Zouhiri, F.; Jeanson, L.; Desmaele, D.; d'Angelo, J.; Mouscadet, J-F.; Gieleciak, R.; Gasteiger, J.; Bret, M.L. Use of the Kohonen Neural Network for Rapid Screening of Ex Vivo Anti- HIV Activity of Styrylquinolines, J. Med. Chem., 2002, 45, 4647- 4654.
70. Niwa, T. Using General Regression and Probabilistic Neural Networks To Predict Human Intestinal Absorption with Topological Descriptors Derived from Two-Dimensional Chemical Structures, J. Chem. Inf. Comput. Sci., 2003, 43, 113-119.
71. Karelson, M.; Karelson, G.; Tamm, T.; Tulp, I.; Jänes, J.; Tämm, K.; Lomaka, A.; Savchenko, D.; Dobchev, D. QSAR study of pharmacological permeabilities. ARKIVOC, 2009, (ii), 218-238.
72. Tobita, M.; Nishikawa, T.; Nagashima, R. A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors. Bioorgan. Med. Chem. Lett., 2005, 15, 2886-2890.
73. Coi, A.; Bianucci, A.M.; Calderone, V.; Testai, L.; Digiacomo, M.; Rapposelli, S.; Balsamo, A.; Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers. Bioorgan Med. Chem., 2009, 17, 5565-5571.
74. Molnar, L.; Keseru, G.M.; Papp, A.; Gulyasc, Z.; Darvasb, F. A neural network based prediction of octanol-water partition coefficients using atomic5 fragmental descriptors. Bioorgan. Med. Chem. Let., 2004, 14, 851-853.
75. Golmohammadi, H.; Dashtbozorgi, Z.; Acree Jr., W.E. Quantitative structure-activity relationship prediction of blood-to-brain partitioning behavior using support vector machine.Euro. J. Pharm. Sci., 2012, 47, 421-429.
76. Piotrowski, P.L.; Sumpter, B.G.; Malling, H.V.; Wassom, J.S.; Lu, P.Y.; Brothers, R.A.; Sega, G.A.; Martin, S.A.; Parang, M. A Toxicity Evaluation and Predictive System Based on Neural Networks and Wavelets, J. Chem. Inf. Model., 2007, 47, 676-685.
77. Dobchev, D.A.; Mäger, I.; Tulp, I.; Karelson, G.; Tamm, T.; Tämm, K.; Jänes, J.; Langel, U.; Karelson, M. Prediction of Cell- Penetrating Peptides Using Artificial Neural Networks. Curr. Comput. Aid. Drug Des., 2010, 6, 79-80.
78. Solmajer; Zupan. Optimisation algorithms and natural computing in drug discovery. Drug Discov. Tod.: Technologies, 2004, 1(3): 247-252
79. Gertrudes, J.C.; Maltarollo, V.G.; Silva, R.A.; Oliveira, P.R.; Honórioa, K.M.; da Silva, A.B.F. Machine Learning Techniques and Drug Design. Cur. Med. Chem., 2012, 19, 4289-4297.